17-beta-estradiol
Endometriosis
Duke UniversityPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Endometriosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ulipristal Acetate Northwestern University | Phase 4 | BB |
Rocuronium Stony Brook University | Phase 4 | BB |
Decapeptyl Sheffield Teaching Hospitals NHS Foundation Trust | Phase 4 | BB |
Cyclic Microgestin 1/20 Endeavor Health | Phase 4 | BB |
Continuous Microgestin 1/20 Endeavor Health | Phase 4 | BB |
View all 30 →
Same molecule, other indications
17-beta-estradiol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →